Why, as a woman interested in women's health and diabetes, I am not rushing to put my patients on HRT

Practical Diabetes International

Volumn 17, Issue 5, 2000, Pages 163-164

  Steel, Judith M ^a  

^a VICTORIA HOSPITAL   (United Kingdom)

Author keywords

Cardiovascular disease; Diabetes mellitus; Hormone replacement therapy

Indexed keywords

ESTROGEN; GESTAGEN;

BREAST CANCER; CANCER RISK; CARDIOVASCULAR DISEASE; DEPRESSION; DIABETES MELLITUS; DISEASE ASSOCIATION; GALLBLADDER DISEASE; HORMONAL THERAPY; HUMAN; MEDICAL PRACTICE; NOTE; POSTMENOPAUSE; PRESCRIPTION; RISK FACTOR; SECONDARY PREVENTION; UTERUS CANCER; VEIN THROMBOSIS; WEIGHT GAIN;

EID: 0033844043     PISSN: 13578170     EISSN: None     Source Type: Journal    
DOI: 10.1002/1528-252X(200007/08)17:5<163::AID-PDI89>3.0.CO;2-Y     Document Type: Note

References (9)

1. Coronary risk factors in postmenopausal type 2 diabetic patients: A case for oestrogen replacement therapy
2. HRT in diabetes: Time for action
3. Postmenopausal oestrogen therapy and cardiovascular disease
4. The risk of acute myocardial infarction after oestrogen and oestrogen-progestogen replacement
5. The risk of myocardial infarction associated with the combined use of oestrogens and progestins in postmenopausal women
6. Postmenopausal oestrogen and progestin use and the risk of cardiovascular disease
7. Breast cancer and hormone replacement therapy: Collaborative reanalysis of data from 51 epidemiological studies of 52705 women with breast cancer and 108411 women without breast cancer
8. Pre-existing risk factors profiles in users and non-users of hormone replacement therapy: Prospective cohort study in Gothenburg, Sweden
9. Randomised trial of estrogen plus progestin for secondary prevention of coronary heart disease in postmenopausal women